LGND

EPS: -0.67 Rev: 52M Net Inc: -13M

Income Statement

Expenses

Assets

Assets (Current)

Assets (Non-Current)

Liabilities

Liabilities (Current)

Liabilities (Non-Current)

Cash Flow

Cash Flow Investing

Dimension Breakdowns

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax

srt:ProductOrServiceAxis

Parent Members

Top Products (by latest quarter)

Leaf Members - Contract Revenue And Other Income Member

Leaf Members - Financial Royalty Assets Member

Leaf Members - Intangible Royalty Assets Member

LGND vs Biotechnology (37 peers) - Healthcare

Gross Margin

97.7%

+19.2pp vs peers

Operating Margin

15.3%

-21.2pp vs peers

Net Margin

46.4%

+16.5pp vs peers

ROIC

7.9%

-49.7pp vs peers

Dimension Breakdowns

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis

Leaf Members

us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

us-gaap:AwardTypeAxis

Leaf Members

Related: REGN INCY VRTX CPRX UTHR ALKS JAZZ MRNA PTCT APLS